Maximizing your chances for success. Perspectives from big, small and global
life sciences companies.
Wednesday, May 27th
6.30 pm - 9.00 pm at
Gilead
333 Lakeside Drive, Foster City, CA 94404
-
Directions
Strategic alliances are becoming vital
for biotech companies, as a key to share risks and rewards. Learn from
small, big, and global life sciences companies on how to build a symbiotic
and healthy alliance.
Panel of experts
Xavier Avat
- Director Global Alliance Management, Gilead
Lessons learned from starting a new Alliance Management department. What
structure works best to keep relationships and business running smoothly
for the common good.
Steve Benner
-
M.D., Senior Vice
President and Chief Medical Officer OncoMed Pharmaceuticals
The talk will be about the
Oncomed-GSK alliance and what Oncomed does to make an alliance work with a
big pharmaceutical company and about the lessons learned from that
collaboration.
Christophe Degois
– Biotech
Executive specializing in Marketing – Business Development – Global
Operations
Managing alliances in different countries with different partners for the
same compound. How to support your partners to maximize sales outside the
U.S. How to influence your partners to pay attention to your product and
evaluate their performance. Moderator:
Norma Watenbaugh - Founding Principal Phoenix Consulting Group
Biographies
Xavier Avat joined
Gilead in 2008 as Director Alliance Management where he is in charge of
the HIV collaborations, including Atripla, a first in one pill complete
regimen to treat HIV infection. Prior to Gilead, Xavier was at Schering
Plough Corporation, where he
contributed to building and establishing the Alliance Department through
organizational changes and new processes. Before that, Xavier spent close
to five years at Genentech where he held different functions including
head of the International Operations. In this
role, Xavier was supporting Genentech ex-US assets, including strategic
and corporate planning. He later joined the newly created Alliance
Management department at Genentech
Christophe Degois is currently a
consultant in the biotech industry, helping biotech companies in the areas
of business development, alliance management and international
development. Degois was previously Senior Director, Head of Corporate and
Business Development at FACET Biotech (previously PDL BioPharma) where he
led the successful negotiation of the co-development deal of elotuzumab with
BMS. Christophe joined PDL BioPharma in April 2005, as Senior Director,
Commercial Development. Prior to PDL,
Christophe spent 4 years at Genentech. His last position was Senior
Director of Global Alliances and Operations. Degois started his career in
the pharmaceutical industry at Eli Lilly and Company in sales and
marketing, both in
Indianapolis and Paris and then joined Schering Plough.
Dr. Benner is a medical
oncologist with extensive experience in drug development. While at
OncoMed, Dr. Benner was actively involved in the creation of the
OncoMed-GSK collaboration and serves on the collaboration’s Joint Steering
Committee. Prior to joining OncoMed, Dr. Benner was Sr. Vice President
and Chief Medical Officer for PDL Biopharma. Previous to his work at PDL,
Dr. Benner held a series of positions of increasing responsibility at
Bristol-Myers Squibb. While there he held leadership roles in clinical
oncology, drug development and licensing, culminating in his position as
Vice President in the company’s Pharmaceutical Research Institute.
Norma Watenpaugh,
Principal Phoenix Consulting Group and Chair of the Best Practices
Committee for the Association of Strategic Alliance Professionals
(ASAP). As acknowledged experts in partnering best practices, PhoenixCG
has served prominent clients such as Cisco Systems, Lilly, Dupont and
UPS. PhoenixCG have delivered alliance best practices seminars for the
Stanford University Digital Vision Fellowship Program, Duke Corporate
Education, and the American Management Association as well as many
corporate clients.
Thank you to our generous sponsor
Pre-registrations are closed.
...
$30 at the
door
Cancellations must be made 5-days prior to the
event date
Any cancellation within a 5-day period of the scheduled date will not
be refunded
Name of guests will be kept at the door
The French-American Chamber of Commerce of San Francisco thanks its first
Benefactor Member:
Barclais USA
________________________________________
French-American Chamber of Commerce
703 Market Street, Suite 450, San Francisco, CA
94103
